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Abstract  
BACKGROUND: Diarrhea remains the most common inf ectious disease worldwide. Zinc has been studied 
extensiv ely  recently f or its potential eff ect on prev ention, control and treatment of  acute diarrhoea. 
AI M:  This study  was designed to correlate the lev el of  zinc with  the sev erity  of  pediatric diarrhoea estimated by  
Vesikari Scoring Sy stem. 
PATIENTS AND METH ODS: The present study  included 80 children aged t wo months to 30 months f rom those 
suff ering f rom the acute diarrheal  episode and admitted to Pediatric Hospital "Abo El Rish" Cairo Univ ersity . 
Serum Zinc lev el was assessed by  a colorimetric method with a spectrophotometer. 
RESULTS: Zinc def iciency was detected in 45 (56.2%) patient of the studied group Signif icant negativ e 
correlations were f ound bet ween serum zinc lev el and sev erity of  dehy dration and duration of  hospitalization (p < 
0.05). 
CONCLUSION: Zinc lev el has an essential role in  acute pediatric diarrhoea. Zinc therapy  should be considered 
beside Oral rehy dration salts (ORS) to achiev e maximum impact on diarrheal diseases; clinical trials are 
recommended to support the zinc supplementation in dev eloping countries.  
 
  
 
 
 
Introduction 
 
Diarrheal disease remains the most common 
infectious disease worldwide and still presenting the 
third cause of mortality among children younger than 
five years of age [1, 2]. In developing countries, acute 
diarrhoea was reported to cause a significant mortality 
rate. On the other hand, it is rarely fatal in the 
developed countries. However, acute diarrhoea was 
considered a leading cause of emergency department 
visits and hospitalizations causing a significant 
economic burden [3].  
The clinical spectrum of the diarrheal disease 
range from a self-limiting disease with the potential of 
short hospitalization for few days up to more 
prolonged disease that may be complicated by severe 
dehydration, malnutrition, and death [4].  
These differences had generated different definitions. 
Moreover; different treatment protocols and diversity 
in recommendations of diarrheal diseases [5]. 
According to the WHO recommendations; 
acute diarrheal main treatment is the prevention of 
dehydration with adequate liquids and oral rehydration 
salts (ORS) maintenance of oral feeding, and 
supplementation of zinc [6]. 
Zinc considered as an essential trace element 
required for normal intestinal mucosal integrity, 
sodium and water transport and immune function [7].  
Unfortunately, 30% of the world’s population is zinc 
deficient [8].  
The role of zinc level and its association with 
the outcome of acute pediatric diarrhoea has been 
studied evidently over the last years in both 
developing and developed countries showing a 
potential effect of zinc in reducing complications and 
mortality rates [9-11]. 
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In developed countries, some guidelines 
recommend the use of zinc in addition to the ORS and 
oral feeding maintenance [12-14].  
The present study was designed to estimate 
serum zinc level in children with acute diarrhoea and 
its correlation with the severity of diarrhoea estimated 
by Vesikari Scoring System. 
 
 
Subjects and Methods 
 
The present study was conducted on 80 
children aged from 2 months to 30 months from those 
diagnosed as having acute diarrheal episodes 
according to the WHO criteria and admitted to Abo El 
Rish Pediatric Hospital, Cairo University from 
February 2016 to October 2016.  
Children came to the clinic suffered from 
acute diarrhoea was screened for inclusion and 
exclusion criteria. Those fulfilled the criteria were 
considered for sampling. According to their number, a 
systematic technique random sampling was used to 
select the desired number. Children with acute 
diarrhoea were included. Any child with history 
suspecting surgical or extra intestinal causes of 
diarrhoea or receiving immunosuppressive therapy 
were excluded from the study.  
The study followed the regulations of the 
medical ethical committee of the Cairo University. 
Signed informed consents were collected from 
mothers of the children enrolled in the study before 
participation. Demographic data and medical history 
were collected from the mothers via questionnaires.  
Acute diarrhoea was defined as caregiver’s 
report of ≥ three loose or watery stools in a 24-hour 
period [7]. The clinical picture and severity degree of 
each case was assessed based on a direct 
examination and categorized into mild, moderate and 
severe using a clinical scoring system (Vesikari 
Scoring System) [15].  
Table 1: Vesikari Scoring System  
Parameter  1 2 3 
Diarrhea    
Maxi mum number stools per day 1–3 4–5 ≥6 
Diarrhea duration (day) 1–4 5 ≥6 
Vomiti ng    
Maxi mum number per day 1 2–4 ≥5 
Vomiti ng duration (day)  1 2 ≥3 
Maxi mum body temperature (℃) 37.1–38.4 38.5–38.9 ≥39.0 
Severity of dehydration (%)  N/A 1–5 ≥6 
Treatment Rehydrati on Hospitalizati on N/A 
Severity rati ng scales  <7  
(mild) 
7–10 
(moderate)  
≥11 
(severe) 
 
Vesikari Scoring System (VSS) can be 
considered a useful and reliable infectious marker for 
pediatric gastroenteritis are enabling development of 
an early treatment plan and recently verified by many 
studies [16, 17] (Table 1).  
 
Laboratory investigations 
Blood Sample was collected using plain tubes 
and let to stand until clotting. Clotted blood was 
centrifuged, separated, and serum transferred into 
aliquots stored frozen at -20°C. Zinc level was 
estimated by using the colorimetric method with a 
spectrophotometer wavelength 560 nm (Atomic 
Absorption Spectrometer equipped with a graphite 
furnace atomizer and an auto-sampler; Quimica 
Clinica Aplicada S.A. Company, Amposta, Spain). The 
normal serum zinc level was considered for values of 
60–110 μg/dl.  
 
Statistical analysis 
Statistical analysis was performed using the  
SPSS statistical package software for windows 
version 21 (SSPS Inc, Pennsylvania, USA). 
Parametric variables are described as the mean ± SD. 
Pearson’s correlation coefficients were used to 
evaluate correlations between the data exhibiting 
parametric distribution. P value < 0.05 was considered 
significant difference and p < 0.005 was considered 
highly significant difference.  
 
 
Results 
 
The descriptive and clinical data are 
demonstrated in table 2. The mean age of the 
included children was ..11  ±915  months.  
According to the collected clinical data, 57 
(71.3%) cases were reported to have a fever and 52 
(65%) cases were associated with vomiting.  
Table 2: Demographic and clinical data of studied children 
 "Minimum 
and maximum."  
Mean ± SD  
Age (months)  3 - 30 11.2 ± 5.9 
Weight (Kg)  4 - 13.5 8.1 ± 2.3 
Duration of hospitalizati on (days)  1 - 6 2.3 ±1.3 
 No % 
Vomiti ng 52 65.0 
Fever 57 71.3 
Dehydrati on 
Mild 
Moderate  
Severe 
66 
27 
27 
12 
82.5 
40.9 
40.9 
18.2 
ICU admission 9 11.3 
VVS Score:  
 Mild <7 
 Moderate 7-10 
 Sever e ≥11 
 
0 
10 
70 
 
0 
12.5 
87.5 
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Dehydration degree ranged from mild to 
severe. Out of 80 studied cases, 66 children (82.5%) 
suffered from dehydration. Out of them, 27 (40.9%) 
child as a mild dehydration, 27 (40.9%) child as a 
moderate degree of dehydration while 12 children 
(18.2%) suffered from a severe degree of dehydration 
with 9 cases with ICU admission.The duration of 
hospitalization ranged from 1 to 6 days. 
The VSS was applied to all cases; 10 (12.5%) 
cases were scored as moderate, and 70 (87.5%) 
cases were scored as severe. 
Zinc level ranged from 50 – 101 µg/dl with the 
mean 65.0 ± 13.5 µg/dl. The studied cases were then 
subdivided into two groups according to the cutoff 
value of serum zinc level which is 60 µg/dl.  Zinc 
deficiency was present in 45 (56.2%) cases (Table 3). 
Table 3: Zinc level in studied children  
  Range Mean ± SD  
Serum Zinc level (µg/dl) 50 – 101 65.0 ± 13.5 
Zinc level:  
 < 60 µg/dl  
 > 60 µg/dl  
No % 
45 
35 
56.2 
43.8 
 
A significant negative correlation was noticed 
between zinc level and the diarrhoea severity 
parameters as the severity of dehydration (p < 0.001), 
duration of hospitalization (p < 0.01) and VSS scoring 
(p<0.001) as shown in (Table 4). 
Table 4: Correlations between serum zinc and diarrheal 
severity parameters 
 Age in months  
Dehydrati on 
severity 
Duration of  
hospitalization 
VSS 
score 
Zinc 
level 
Pearson 
Correlation 
0.593**  -0.429**  -0.269*  
-0.496**  
Sig. (2-tailed)  0.000 0.000 0.016 0.000 
* Correlation is significant at the 0.01 level (2-tailed). ** Correlati on is highl y significant at 
the 0.001 level (2-tailed). 
 
 
Discussion 
 
Acute diarrhoea considered as a leading 
cause of childhood mortality despite the remarkable 
achievement of oral rehydration therapy (ORT) in 
acute diarrheal diseases treatment over the years [1].  
Oral rehydration salts (ORS) solution and 
ORT were adopted by the World Health Organization 
(WHO) and the United Nations Children’s Fund 
(UNICEF) since 1978 as the first line tool in 
dehydration management, causing reduction in the 
mortality rate of children aged five and less diagnosed 
as acute diarrhea from 4.5 million to 1.8 million every 
year. However, in spite of this undeniable 
achievement, acute diarrhoea remains a leading 
cause of death in children in developing countries [.1, 
18].  
Frequent episodes of acute diarrhoea can 
compromise zinc level due to increased faecal zinc 
loses during the episode that could be associated with 
negative zinc balance. Additionally, zinc stores are 
limited and rapidly depleted by acute intestinal illness 
[19]. In the developing countries, the high prevalence 
of diarrheal episodes was reported to increases the 
risk of zinc deficiency [20]. 
In the present  study, zinc deficiency was 
detected in 45 (56.2%) cases of the studied children. 
A significant negative correlation was noticed between 
zinc level and the severity of the disease measured by 
VSS. 
This finding is in favour to many studies that 
reviewed the degree of diarrhoea control and 
treatment achieved by zinc  supplementation.  Some 
studies focused on the mechanisms by which zinc 
might contribute to the pathogenesis of acute 
diarrhoea [21-26].  
Zinc deficiency has been linked to the severity 
of diarrheal episodes [21]. Moreover, Zinc supplement 
significantly reduced the duration of illness [22].  
The current WHO/UNICEF Joint Statement on 
Clinical Management of Acute Diarrhea recommends 
10–20 mg zinc/d (dependent on age) for 10–14 d for a 
reduction in diarrhoea duration and severity (the 
therapeutic benefit) and prevention of subsequent 
episodes (the “secondary prevention” benefit) [18]. 
Unfortunately, the WHO/UNICEF strategy for 
zinc supplementation as adjunctive therapy for 
diarrhoea is poorly implemented [27].  
A significant negative correlation was noticed 
between zinc level and the diarrhoea severity 
parameters as the severity of dehydration (p< 0.001), 
duration of hospitalization (p < 0.01) and VSS scoring 
(p < 0.001).  
These findings are in favour to the finding of a 
systematic review by Lamberti et al., [28] that confirm 
and highlight the benefits of therapeutic zinc 
supplementation for diarrhoea among children aged 
five and less in low- and middle-income countries. The 
effects of zinc treatment, which include reductions in 
episode duration,  stool output, stool frequency and 
length of hospitalization.  
In conclusion, zinc level has an essential role 
in acute pediatric diarrhoea .For maximum impact on 
diarrheal diseases, improvement zinc therapy should 
be considered beside ORS. Clinical trials are 
recommended to support the zinc supplementation in 
developing countries. 
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